egf

Complex Rab4-Mediated Regulation of Endosomal Size and EGFR Activation

Early sorting endosomes are responsible for the trafficking and function of transferrin receptor (TfR) and EGFR. These receptors play important roles in iron uptake and signaling and are critical for breast cancer development. However, the role of morphology, receptor composition, and signaling of early endosomes in breast cancer remains poorly understood. A novel population of enlarged early endosomes was identified in breast cancer cells and tumor xenografts but not in noncancerous MCF10A cells. Quantitative analysis of endosomal morphology, cargo sorting, EGFR activation, and Rab GTPase regulation was performed using super-resolution and confocal microscopy followed by 3D rendering. MDA-MB-231 breast cancer cells have fewer, but larger EEA1-positive early endosomes compared with MCF10A cells. Live-cell imaging indicated dysregulated cargo sorting, because EGF and Tf traffic together via enlarged endosomes in MDA-MB-231, but not in MCF10A. Large EEA1-positive MDA-MB-231 endosomes exhibited prolonged and increased EGF-induced activation of EGFR upon phosphorylation at tyrosine-1068 (EGFR-p1068). Rab4A overexpression in MCF10A cells produced EEA1-positive enlarged endosomes that displayed prolonged and amplified EGF-induced EGFR-p1068 activation. Knockdown of Rab4A lead to increased endosomal size in MCF10A, but not in MDA-MB-231 cells. Nevertheless, Rab4A knockdown resulted in enhanced EGF-induced activation of EGFR-p1068 in MDA-MB-231 as well as downstream signaling in MCF10A cells. Altogether, this extensive characterization of early endosomes in breast cancer cells has identified a Rab4-modulated enlarged early endosomal compartment as the site of prolonged and increased EGFR activation.

Implications:

Enlarged early endosomes play a Rab4-modulated role in regulation of EGFR activation in breast cancer cells.




egf

Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF-Resistant Diabetic Macular Edema

Approximately 40% of patients with diabetic macular edema (DME) are resistant to anti–vascular endothelial growth factor (VEGF) therapy (rDME). Here, we demonstrate that significant correlations between inflammatory cytokines and VEGF, as observed in naive DME, are lost in patients with rDME. VEGF overexpression in the mouse retina caused delayed inflammatory cytokine upregulation, monocyte/macrophage infiltration (CD11b+ Ly6C+ CCR2+ cells), macrophage/microglia activation (CD11b+ CD80+ cells), and blood-retinal barrier disruption due to claudin-5 redistribution, which did not recover with VEGF blockade alone. Phosphorylated protein analysis of VEGF-overexpressed retinas revealed rho-associated coiled-coil–containing protein kinase (ROCK) activation. Administration of ripasudil, a selective ROCK inhibitor, attenuated retinal inflammation and claudin-5 redistribution. Ripasudil also contributed to the stability of claudin-5 expression by both transcriptional enhancement and degradation suppression in inflammatory cytokine–stimulated endothelium. Notably, the anti-VEGF agent and the ROCK inhibitor were synergic in suppressing cytokine upregulation, monocyte/macrophage infiltration, macrophage/microglia activation, and claudin-5 redistribution. Furthermore, in vitro analysis confirmed that claudin-5 redistribution depends on ROCK2 but not on ROCK1. This synergistic effect was also confirmed in human rDME cases. Our results suggest that ROCK-mediated claudin-5 redistribution by inflammation is a key mechanism in the anti-VEGF resistance of DME.




egf

Correction: EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas




egf

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Purpose:

Currently, an optimal therapeutic strategy comprising molecularly targeted agents for treating EGFR-mutated non–small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib is not available. Therefore, the initial therapeutic intervention is crucial for the prolonged survival of these patients. The activation of anexelekto (AXL) signaling is known to be associated with intrinsic and acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs). In this study, we investigated the best therapeutic strategy to combat AXL-induced tolerance to EGFR-TKIs using the novel AXL inhibitor ONO-7475.

Experimental Design:

We examined the efficacy of ONO-7475 in combination with EGFR-TKIs in EGFR-mutated NSCLC cells using in vitro and in vivo experiments. We investigated the correlation between AXL expression in tumors and clinical outcomes with osimertinib for EGFR-mutated NSCLC patients with acquired resistance to initial EGFR-TKIs.

Results:

ONO-7475 sensitized AXL-overexpressing EGFR-mutant NSCLC cells to the EGFR-TKIs osimertinib and dacomitinib. In addition, ONO-7475 suppressed the emergence and maintenance of EGFR-TKI–tolerant cells. In the cell line–derived xenograft models of AXL-overexpressing EGFR-mutated lung cancer treated with osimertinib, initial combination therapy of ONO-7475 and osimertinib markedly regressed tumors and delayed tumor regrowth compared with osimertinib alone or the combination after acquired resistance to osimertinib. AXL expression in EGFR-TKI refractory tumors did not correlate with the sensitivity of osimertinib.

Conclusions:

These results demonstrate that ONO-7475 suppresses the emergence and maintenance of tolerant cells to the initial EGFR-TKIs, osimertinib or dacomitinib, in AXL-overexpressing EGFR-mutated NSCLC cells, suggesting that ONO-7475 and osimertinib is a highly potent combination for initial treatment.




egf

New Drug-Discovery Assay Identifies Novel Mutant-EGFR Inhibitors [Drug Discovery]

The MaMTH-DS assay detected inhibitors of mutant EGFR in non–small cell lung cancer cells.




egf

Roy Horn, Half of ‘Siegfried and Roy,’ Dies of Coronavirus

Ethan Miller/Getty

Roy Horn, half of the iconic magician duo Siegfried and Roy, has died from complications of the new coronavirus in Las Vegas. He was 75.

Together with Siegfried Fischbacher, Horn, born Uwe Ludwig Horn, created one of the most widely known magic acts in the world, staging shows filled with sleights of hand and exotic animals for packed audiences in Las Vegas for more than a decade. At its height, the glitzy show grossed $45 million per year, according to The Hollywood Reporter, among the highest ever in Las Vegas.

“Today, the world has lost one of the greats of magic, but I have lost my best friend,” Fischbacher said in a statement. “There could be no Siegfried without Roy, no Roy without Siegfried.” Fischbacher thanked the doctors and nurses who cared for his friend.

Read more at The Daily Beast.




egf

Siegfried & Roy Magician Roy Horn Dead at 75 Due to COVID-19 Complications

“Today, the world has lost one of the greats of magic, but I have lost my best friend,” Siegfried Fischbacher said in a statement.




egf

RIP Roy Horn: Fans and Celebrities Remember the Siegfried and Roy Magician

Half of the legendary Las Vegas magic duo died on Friday following complications from COVID-19.




egf

Roy Horn of Vegas duo Siegfried & Roy dead from coronavirus

The magician survived an attack by a 380-pound tiger, who bit his neck during a show at the Mirage Las Vegas in 2003.




egf

Roy Horn of Las Vegas magic duo Siegfried and Roy dies of COVID-19: report

Magician Roy Horn, who alongside Siegfried Fischbacher starred in a popular, long-running Las Vegas act built around rare tigers, died on Friday from of complications of COVID-19, the Las Vegas Review-Journal newspaper reported. He was 75.




egf

Roy Horn from Las Vegas magic duo Siegfried and Roy dead at 75 of COVID-19 complications

'Today, the world has lost one of the greats of magic, but I have lost my best friend,' Siegfried Fischbacher said in a statement




egf

Roy Horn of Siegfried & Roy Dies of Coronavirus at 75

Roy Uwe Ludwig Horn, whose collaboration with Siegfried Fischbacher created the well-known animal training and magic duo Siegfried & Roy, died of complications from COVID-19 Friday in Las Vegas. He was 75. Horn had revealed on April 28 that he had tested positive for coronavirus. “Today, the world has lost one of the greats of […]




egf

Roy Horn of Siegfried & Roy Dead at 75 From Coronavirus

Roy Horn of the famous Siegrfried & Roy duo has died at the age of 75 from complications caused by the coronavirus. According to a press release, the legendary performer succumbed to...




egf

Roy Horn death: Magician of famous duo Siegfried and Roy dies aged 75 from coronavirus

'Roy was a fighter his whole life including during these final days,' his partner Siegfried Fischbacher said




egf

Roy Horn of Siegfried & Roy Dies of Coronavirus...


Roy Horn of Siegfried & Roy Dies of Coronavirus...


(Second column, 1st story, link)


Drudge Report Feed needs your support!   Become a Patron




egf

Roy Horn of Siegfried & Roy Dead at 75 From Coronavirus

Roy Horn of the famous Siegrfried & Roy duo has died at the age of 75 from complications caused by the coronavirus. According to a press release, the legendary performer succumbed to...




egf

Roy Horn Dies Of Coronavirus: Siegfried & Roy Performer Who Conquered Las Vegas Was 75

Roy Horn, who thrilled Las Vegas crowds as part of the big-cats-and-magic act Siegfried & Roy until a tiger attack ended his career in 2003, died today of coronavirus at Mountain View Hospital in Las Vegas. He was 75. Horn’s publicist said on April 28 that the magician had tested positive for COVID-19. “Today, the […]




egf

Roy Horn of famed Vegas act Siegfried & Roy dies at age 75 of coronavirus complications

Roy Horn of Siegfried & Roy, the duo whose extraordinary magic tricks astonished millions until Horn was critically injured in 2003 by one of the act's famed white tigers, has died. He was 75.




egf

Roy Horn of Siegfried & Roy Dead at 75 From Coronavirus

Roy Horn of the famous Siegrfried & Roy duo has died at the age of 75 from complications caused by the coronavirus. According to a press release, the legendary performer succumbed to...




egf

Las Vegas star Roy Horn of Siegfried & Roy dies with COVID-19

Magician Roy Horn, best known as part of the Las Vegas performing duo of Siegfried & Roy, has died at the age of 75 after contracting coronavirus.




egf

Roy Horn of Siegfried and Roy Dead at 75 After Catching COVID-19

Roy Horn, one half of the famous Siegfried & Roy magic and entertainment act in Las Vegas, is dead after being infected with the coronavirus ... TMZ has learned. We just got a statement from Siegfried, who told us, "Today, the world has lost…




egf

Biocon/Mylan launch pegfilgrastim biosimilar Fulphila in Australia

US-based drugmaker Mylan and partner India-based biologicals specialist Biocon have announced the launch of their pegfilgrastim biosimilar, Fulphila, in Australia. The drug can be used to treat neutropenia (a lack of white blood cells) in cancer patients.




egf

Pegfilgrastim biosimilar Fulphila launched in Canada

US-based drugmaker Mylan and partner, India-based biologicals specialist Biocon, announced on 28 April 2020 the launch of their pegfilgrastim biosimilar, Fulphila, in Canada. This is the second biosimilar from the pair to be launched in the country.




egf

Roy Horn, dark-haired half of flamboyant illusionists Siegfried & Roy, dies of coronavirus-related complications

Roy Horn, the dark-haired half of Siegfried & Roy, raised the white tigers and other animals in the duo's extravagant shows that were one of the biggest draws on the Las Vegas Strip.




egf

<i>KRAS</i> amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy




egf

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma




egf

VEGF receptor (VEGFR)

Zebrafish studies suggest VEGFR inhibitors could help treat tuberculosis.




egf

Epidermal growth factor receptor 1 (EGFR1; ErbB1; HER1); HER2 (EGFR2; ErbB2; neu); HER3 (EGFR3; ErbB3); VEGF

Tumor cell and mouse studies suggest tetravalent antibodies that target four different antigens could help treat cancers resistant to HER-targeted therapies.




egf

Roy Horn of Vegas duo Siegfried & Roy dead at 75 from coronavirus

Roy Horn met Siegfried Fischbacher on a cruise ship.




egf

Roy Horn of Las Vegas's famous Siegfried and Roy act dies from Covid-19

Horn was famed for introducing a pet cheetah to the magic show and was mauled on stage by a tiger in 2003

Roy Horn of Siegfried & Roy, the duo whose extraordinary magic tricks astonished millions until Horn was critically injured in 2003 by one of the act’s famed white tigers, has died from coronavirus complications. He was 75.

Horn died of on Friday in a Las Vegas hospital, according to a statement released by his publicist Dave Kirvin.

Continue reading...




egf

Legendary Vegas magician Roy Horn Siegfried and Roy dies at 75 after coronavirus battle

Legendary magician Roy Horn has died. He was 75. Horn,one half of the longtime Las Vegas illusionist duo Siegfried & Roy, had tested positive for COVID-19.




egf

Legendary magician Roy Horn of Siegfried and Roy has died from complications related to the coronavirus

Roy Horn, one half of the Las Vegas magic duo Siegfried & Roy, has died aged 75 due to coronavirus complications.Horn's publicist Dave Kirvin confirmed that he died in a Las Vegas hospital on Friday after testing positive for the coronavirus last week."Today, the world has lost one of the greats of magic, but I have lost my best friend," read a statement from Siegfried Fischbacher.Visit Insider's homepage for more stories.Roy Horn of the iconic Siegfried & Roy magic duo has died aged 75 from complications related to the coronavirus.The legendary magician died at Mountain View Hospital in Las Vegas on Friday, his publicist Dave Kirvin confirmed. He added that Horn had tested positive for the coronavirus last week, according to the New York Times.The German-born double act, Horn and Siegfried




egf

Roy Horn, of magical duo Siegfried and Roy, dies

Roy Horn, half of Las Vegas illusionist duo Siegfried and Roy, died Friday of complications from the coronavirus. He was 75.Known for his work with big cats,...




egf

Legendary Vegas magician Roy Horn Siegfried and Roy dies at 75 after coronavirus battle

Legendary magician Roy Horn has died. He was 75. Horn,one half of the longtime Las Vegas illusionist duo Siegfried & Roy, had tested positive for COVID-19.




egf

Roy Horn of Siegfried & Roy dies from coronavirus at 75

Roy Horn of Siegfried & Roy, the duo whose extraordinary magic tricks astonished millions until Horn was critically injured in 2003 by one of the act's famed white tigers, has died. He was 75. Horn died of complications from the coronavirus on Friday in a Las Vegas hospital, according to a statement released by publicist Dave Kirvin. Today, the world has lost one of the greats of magic, but I have lost my best friend, Siegfried Fischbacher said in the statement. From the moment we met, I knew Roy and I, together, would change the world. There could be no Siegfried without Roy, and no Roy without Siegfried. He was injured in October 2003 when a tiger named Montecore attacked him on stage at the Mirage hotel-casino in Las Vegas. He had severe neck injuries, lost a lot of blood and later suffered a stroke. He underwent lengthy rehabilitation, but the attack ended the long-running Las Vegas Strip production. The darker-haired of the flashy duo, Horn was credited with the idea of ...




egf

Roy Horn of Las Vegas magic duo Siegfried and Roy dies of COVID-19: report

Magician Roy Horn, who alongside Siegfried Fischbacher starred in a popular, long-running Las Vegas act built around rare tigers, died on Friday from of complications of COVID-19, the Las Vegas Review-Journal newspaper reported. He was 75.




egf

Roy Horn of Las Vegas magic duo Siegfried and Roy dies of COVID-19 - report

Magician Roy Horn, who alongside Siegfried Fischbacher starred in a popular, long-running Las Vegas act built around rare tigers, died on Friday from of complications of COVID-19, the Las Vegas Review-Journal newspaper reported. He was 75.




egf

Tetrahedral DNA Nanostructure-decorated Electrochemical Platform for Simple and Ultrasensitive EGFR Genotyping of Plasma ctDNA

Analyst, 2020, Accepted Manuscript
DOI: 10.1039/D0AN00591F, Paper
Xuyao Wang, Jianping Wu, Weilin Mao, Xia He, Liming Ruan, Junlan Zhu, Peng Shu, Zhenqi Zhang, Bitao Jiang, Xingguo Zhang
Genotyping of the epidermal growth factor receptor (EGFR) mutation status is of great importance in the screening of appropriate advanced non-small cell lung carcinoma (NSCLC) patients to receive superior tyrosine...
The content of this RSS Feed (c) The Royal Society of Chemistry




egf

[ASAP] Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.9b01336




egf

[ASAP] Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.9b00574




egf

[ASAP] Complete Regression of Carcinoma via Combined C-RAF and EGFR Targeted Therapy

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.0c00159




egf

The number of the heavens: a history of the multiverse and the quest to understand the cosmos / Tom Siegfried

Hayden Library - QB981.S5346 2019




egf

The curious humanist: Siegfried Kracauer in America / Johannes von Moltke

Hayden Library - PT2621.R135 Z94 2016




egf

miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway

Toxicol. Res., 2019, 8,875-884
DOI: 10.1039/C9TX00100J, Paper
Xuan-Ying Chen, Wei-Lin Huang, Xiao-Ping Peng, Yan-Ni Lv, Jun-He Li, Jian-Ping Xiong
Bevacizumab (BVZ) is a widely investigated angiogenesis inhibitor in cancer patients. Although the anti-tumor effects has been verified, cardiotoxicity may be the most serious side-effect for BVZ.
The content of this RSS Feed (c) The Royal Society of Chemistry




egf

Corneal Neo-vascularization and VEGF Expression in Pinnipeds




egf

Hanko to step down at Siegfried